J. Vágner

Publications109
h-index26
Citations2,243
Highly Influential Citations28
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • V. Hruby
  • 1,336 Publications, 33,253 Citations
  • T. Price
  • 207 Publications, 5,481 Citations
  • R. Gillies
  • 389 Publications, 32,307 Citations
  • M. Hollenberg
  • 563 Publications, 23,462 Citations
  • Publications
  • Influence
Noninvasive continuous monitoring of solid-phase peptide synthesis by acid-base indicator.
Utilisation du bleu de bromophenol pour suivre l'acylation de groupes amino en synthese peptidique en phase solide
  • 191
  • 4
  • PDF
The MNK–eIF4E Signaling Axis Contributes to Injury-Induced Nociceptive Plasticity and the Development of Chronic Pain
Injury-induced sensitization of nociceptors contributes to pain states and the development of chronic pain. Inhibiting activity-dependent mRNA translation through mechanistic target of rapamycin and… Expand
  • 62
  • 3
  • PDF
Lanthanide-based time-resolved fluorescence of in cyto ligand-receptor interactions.
A lanthanide-based assay for ligand-receptor interactions provides an attractive alternative to the traditional radiolabeled determinations in terms of sensitivity, throughput, and biohazards. We… Expand
  • 58
  • 2
Enhanced targeting with heterobivalent ligands
A novel approach to specifically target tumor cells for detection and treatment is the proposed use of heteromultivalent ligands, which are designed to interact with, and noncovalently crosslink,… Expand
  • 49
  • 2
  • PDF
Development of melanoma-targeted polymer micelles by conjugation of a melanocortin 1 receptor (MC1R) specific ligand.
The incidence of malignant melanoma is rising faster than that of any other cancer in the United States. Because of its high expression on the surface of melanomas, MC1R has been investigated as a… Expand
  • 34
  • 2
  • PDF
Solid-phase synthetic strategy and bioevaluation of a labeled delta-opioid receptor ligand Dmt-Tic-Lys for in vivo imaging.
A general solid-phase synthetic strategy is developed to prepare fluorescent and/or lanthanide-labeled derivatives of the delta-opioid receptor (deltaOR) ligand H-Dmt-Tic-Lys(R)-OH. The high delta-OR… Expand
  • 24
  • 2
The novel PAR2 ligand C391 blocks multiple PAR2 signalling pathways in vitro and in vivo
Proteinase‐activated receptor‐2 (PAR2) is a GPCR linked to diverse pathologies, including acute and chronic pain. PAR2 is one of the four PARs that are activated by proteolytic cleavage of the… Expand
  • 23
  • 2
Peptidomimetics, a synthetic tool of drug discovery.
The demand for modified peptides with improved stability profiles and pharmacokinetic properties is driving extensive research effort in this field. Many structural modifications of peptides guided… Expand
  • 327
  • 1
Heterobivalent ligands crosslink multiple cell-surface receptors: the human melanocortin-4 and delta-opioid receptors.
Cell-surface receptor mediated signaling is mechanistically complex. Hetero- and homo-multimerization of receptors appears to occur naturally and is a significant regulatory component of signal… Expand
  • 59
  • 1
Synthesis and evaluation of bivalent NDP-alpha-MSH(7) peptide ligands for binding to the human melanocortin receptor 4 (hMC4R).
We demonstrate the potential utility of multivalent ligands as targeting agents for cancer imaging or therapy by determining the binding of homobivalent ligands to their corresponding receptors. This… Expand
  • 45
  • 1